Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through the courts. Thousands of patients have filed lawsuits claiming the makers of ...

Ashlyn Needham is an expert decor and design writer with 6 years of writing for brands and personal clients. She has been published in The Spruce, Southern Living, House Digest, Family Handyman, and ...

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Originally published on savehealth.com, part of the BLOX ...

Semaglutide (Ozempic, Wegovy) may help reduce the risk of an opioid overdose in certain people, an emulation target trial suggested. Over a 1-year follow-up, people with comorbid type 2 diabetes and ...